TRIP13 and T-cell non-Hodgkin lymphoma: This analysis revealed that TRIP13 was expressed in T-cell lymphoma (T8ML-1, MJ, HH), T-cell leukemia (JURKAT, MOLT4, MOT, SUPT1, LOUCY, CCRF-CEM, DND-41) B-cell lymphoma (RAJI), B-cell leukemia (MEC-1, MEC-2) and myeloid leukemia (K562, CTV-1) cell lines (Fig. 6C).